Applications are now being accepted for the sixth annual Tauber Family Student Internship Program. The 2019 Tauber Family Interns will spend 10 weeks in the laboratory of the Program for Neurology Research & Discovery (PNR&D), which conducts research on amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, and neurological complications related to diabetes.
Internships are awarded to outstanding undergraduate students who attend the University of Michigan or other colleges and universities across the country. During their time in the laboratory, the interns have the opportunity to assist researchers with hypothesis generation, hands-on practice in the laboratory, and follow-up reporting on how their research can impact the scientific community.
Applications must be received by Friday, March 15. Those interested should submit via email a curriculum vitae, transcript, and letter of recommendation to PNR&D Managing Director Stacey Jacoby, Ph.D., at [email protected]. Applicants should also include a brief overview of why they want to work in the laboratory and what research areas are of interest to them.
Testimonial From Past Tauber Family Student Intern
Kristen Raue | B.S., Neuroscience; B.A., Spanish
“I greatly appreciate the support I’ve received from the Tauber Family. My experience working for PNR&D has advanced my growth as a scientist and future medical professional. One aspect of the Feldman Laboratory that sets it apart is the supportive and inclusive environment fostered by the staff. This was particularly helpful throughout the writing of my senior honors thesis. My thesis received high honors, a distinction that would not have been achieved without the backing of the PNR&D team. After graduation, I will be applying to medical school and continue my research at PNR&D as well as in the Department of Neurosurgery.”
About the Program for Neurology Research and Discovery: Under the direction of Eva Feldman, M.D., Ph.D., since 2000, the PNR&D is a group of 30-plus scientists, clinicians, and students who are working toward the common goal of understanding and curing neurological diseases, especially ALS (Lou Gehrig’s disease), Alzheimer’s disease, and diabetic neuropathy